Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
Observational
Observational Model: Cohort, Time Perspective: Retrospective
Evaluate Faslodex therapeutic strategy and treatment duration
At the end of the study
No
Alain FLINOIS
Principal Investigator
TNS Healthcare - France138, avenue Marx Dormoy92120 Montrouge
France: Haute Autorité de Santé Transparency Commission
NIS-OFR-FAS-2007/1
NCT00681369
May 2007
June 2007
Name | Location |
---|